Getting the most out of muscles: Materials that convert electrical, chemical, or thermal energy into a shape change can be used to form artificial muscles. Such materials include bimetallic strips or host-guest materials or coiled fibers or yarns (see the Perspective by Tawfick and Tang). Kanik et al. developed a polymer bimorph structure from an elastomer and a semicrystalline polymer where the difference in thermal expansion enabled thermally actuated artificial muscles. Iterative cold stretching of clad fibers could be used to tailor the dimensions and mechanical response, making it simple to produce hundreds of meters of coiled fibers. Mu et al. describe carbon nanotube yarns in which the volume-changing material is placed as a sheath outside the twisted or coiled fiber. This configuration can double the work capacity of tensile muscles. Yuan et al. produced polymer fiber torsional actuators with the ability to store energy that could be recovered on heating. Twisting mechanical deformation was applied to the fibers above the glass transition temperature and then stored via rapid quenching. Science , this issue p. 145 , p. 150 , p. 155 ; see also p. 125

Arachidonic acid-derived prostaglandins not only contribute to the development of inflammation as intercellular pro-inflammatory mediators, but also promote the excitability of the peripheral somatosensory system, contributing to pain exacerbation. Peripheral tissues undergo many forms of diseases that are frequently accompanied by inflammation. The somatosensory nerves innervating the inflamed areas experience heightened excitability and generate and transmit pain signals. Extensive studies have been carried out to elucidate how prostaglandins play their roles for such signaling at the cellular and molecular levels. Here, we briefly summarize the roles of arachidonic acid-derived prostaglandins, focusing on four prostaglandins and one thromboxane, particularly in terms of their actions on afferent nociceptors. We discuss the biosynthesis of the prostaglandins, their specific action sites, the pathological alteration of the expression levels of related proteins, the neuronal outcomes of receptor stimulation, their correlation with behavioral nociception, and the pharmacological efficacy of their regulators. This overview will help to a better understanding of the pathological roles that prostaglandins play in the somatosensory system and to a finding of critical molecular contributors to normalizing pain.